In a bid to make Germany a more desirable clinical research location, a new bill has been drawn up that would harmonize rules governing advanced therapies and introduce measures to facilitate decentralized clinical trials (DCTs).
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?